P53 protein expression and chemosensitivity to cisplatin in patients with non-small cell lung cancer: a meta-analysis / 南方医科大学学报
Journal of Southern Medical University
;
(12): 770-773, 2008.
Article
in Chinese
| WPRIM
| ID: wpr-280099
ABSTRACT
<p><b>OBJECTIVE</b>To explore the relation between p53 protein expression and chemosensitivity to cisplatin in patients with non-small cell lung cancer (NSCLC).</p><p><b>METHODS</b>The DerSimonian-Laird random effect model was used to analyze the data reported in relevant literature.</p><p><b>RESULTS</b>Sixteen trials involving 1070 patients were retrieved. The overall positivity rate of p53 was 50.4% and overall response rate to cisplatin was 38.7%. The test for heterogeneity showed that all eligible studies had heterogeneity (chi 2-/+47.57, P<0.0001). The combined odds ratio (OR) was 1.37, with 95% confidence interval of 0.84-2.24.</p><p><b>CONCLUSION</b>Expression of p53 protein in patients with NSCLC is not associated with the chemosensitivity to cisplatin.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Clinical Trials as Topic
/
Tumor Suppressor Protein p53
/
Cisplatin
/
Carcinoma, Non-Small-Cell Lung
/
Drug Resistance, Neoplasm
/
Therapeutic Uses
/
Drug Therapy
/
Lung Neoplasms
/
Metabolism
Type of study:
Systematic reviews
Limits:
Humans
Language:
Chinese
Journal:
Journal of Southern Medical University
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS